Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis

Abstract

In moderate-risk patients with severe AS undergoing TAVR, there was a 13% prevalence of ATTR-CA, which did not affect mortality. The observed increase in heart failure hospitalization following TAVR in those with ATTR-CA suggests the consequences of the underlying infiltrative myopathy.